Introducing a New RAPS Member Benefit
Regulatory Focus (RF) Article
The Regulatory Affairs Professionals Society (RAPS) is pleased to announce a quarterly series of electronic publications for RAPS’ Members only. The RF Article Series are comprised of timely and relevant Regulatory Focus technical articles, case studies, interviews and research reports.
These topic-focused collections are intended to benefit RAPS members responsible for healthcare related products. Articles are developed by global subject matter experts representing a wide range of regulatory responsibilities and organizations.
Orphan Drug Regulations: A Global Perspective
Our third Regulatory Focus (RF) article series discusses the global impact of orphan drugs. In this article, regulatory industry leaders share insight and experience on drugs designated for diseases that affect few people with little to no treatment options, also known as orphan drugs. RAPS has brought together leading global regulatory experts to examine and offer their predictions on the future of global orphan drug research, development and regulation.
Individual articles examine:
Other topics to be covered in 2018 include:
- new orphan drug programs in various parts of the world
- orphan drug designation variations
- processes for gaining orphan drug designation
- policy and legislation changes
- orphan drug research and development incentives
- and more
To Access Your Member Benefit, simply login and select the e-Book: Orphan Drug Regulations: A Global Perspective in the Member Knowledge Center.
Login to Gain Access
Not a RAPS Member? RAPS’ Membership gives you access to countless resources and a vast network of professional all dedicated to regulatory. Learn More About RAPS Membership and Benefits.